prof. dr. H.G.M. (Harry) Heijerman

prof. dr. H.G.M. (Harry) Heijerman

Full Professor
prof. dr. H.G.M. (Harry) Heijerman
  • Department of Pulmonary Diseases



Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center  Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology. 

Side Activities

Chairman of the medical advisory board of the Dutch CF Foundation (NCFS)

Advisory board member Vertex Pharmaceuticals (2019)(Payments to UMC Utrecht)



Speaker fees:

Gilead 2020 (payments to UMC Utrecht)

Vertex 2019 (payments to UMC Utrecht)

Research Output (88)

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia

Amatngalim Gimano D, Rodenburg Lisa W, Aalbers Bente L, Raeven Henriette Hm, Aarts Ellen M, Sarhane Dounia, Spelier Sacha, Lefferts Juliet W, Silva Iris Al, Nijenhuis Wilco, Vrendenbarg Sacha, Kruisselbrink Evelien, Brunsveld Jesse E, van Drunen Cornelis M, Michel Sabine, de Winter-de Groot Karin M, Heijerman Harry G, Kapitein Lukas C, Amaral Magarida D, van der Ent Cornelis K, Beekman Jeffrey M Dec 2022, In: Life Science Alliance. 5 , p. 1-14

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis

Terpstra Lotte C., Altenburg Josje, Bronsveld Inez, de Kruif Martijn D., Berk Yvonne, Snijders Dominic, Rozemeijer Wouter, Heijerman Harry G.M., Boersma Wim G. Dec 2022, In: Respiratory research. 23

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype

Aalbers B L, Brunsveld J E, van der Ent C K, van den Eijnden J C, Beekman J M, Heijerman H G M 30 Jan 2022, In: Journal of Cystic Fibrosis. 21 , p. 254-257 4 p.

Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation

Burghard Marcella, Takken Tim, Nap-van der Vlist Merel M, Nijhof Sanne L, van der Ent C Kors, Heijerman Harry G M, Hulzebos H J Erik 12 Jan 2022, In: Therapeutic advances in respiratory disease. 16

The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial

Terpstra Lotte C., Altenburg Josje, Mohamed Hoesein Firdaus A., Bronsveld Inez, Go Shirley, van Rijn Philip A.C., De Jong Pim A., Heijerman Harry G.M., Boersma Wim G. 28 Dec 2021, In: Respiratory Medicine. 192 , p. 1-6

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators

Muilwijk Danya, Bierlaagh Marlou, van Mourik Peter, Kraaijkamp Jasmijn, van der Meer Renske, van den Bor Rutger, Heijerman Harry, Eijkemans René, Beekman Jeffrey, van der Ent Kors 16 Dec 2021, In: Journal of Personalized Medicine. 11 , p. 1-12

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators

Aalbers Bente L, Bronsveld Inez, Hofland Regina W, Heijerman Harry G M 19 Aug 2021, In: Journal of Personalized Medicine. 11 7 p.

Breast development in a 7 year old girl with CF treated with ivacaftor:An indication for personalized dosing?

Jeyaratnam Joshena, van der Meer Renske, Berkers Gitte, Heijerman Harry Gm, Beekman Jeffrey M, van der Ent Cornelis K 23 Jun 2021, In: Journal of Cystic Fibrosis. 20 , p. e63-e66

CFTR Modulators:Does One Dose Fit All?

van der Meer Renske, Wilms Erik B, Heijerman Harry G M Jun 2021, In: Journal of Personalized Medicine. 11 , p. 1-12 12 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet